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 Abstract 
With more than 700,000 new diagnoses annually, congestive heart failure (CHF) is a 
chronic condition that affects the chambers of the heart. When not managed correctly, the 
disease rapidly progresses to substantial fluid volume overload that impacts activities of 
daily living and the overall quality of life. The financial implications for poor CHF 
management cost a mean annual medical expenditure of $33,427 per patient per year. 
The need for a diagnostic and prognostic at-home protocol is needed in the medical 
community, as there is currently no such tool on the market.  Donabedian’s framework 
was used to guide the formulation and interpretation of this research. The purpose of this 
project was to design a CHF protocol using evidence-based research for clinicians 
making home visits to homebound patients with a primary diagnosis of CHF with an 
individualized protocol focusing on disease management, in home support system, 
knowledge base and financial factors for homebound patients.  The protocol was released 
through a snowballing campaign to clinicians who work with CHF, transitional care, or 
homecare who then evaluated the protocol on its perceived efficacy if integrated into 
practice. Findings were analyzed using simple descriptive statistics by 32 nurses and 
other health care professionals who responded work in home care, cardiology, medical 
surgical nursing hospitalists, or skilled nursing facilities. Thirty-one of the 32 respondents 
deemed the protocol useful and stated a clinical need of protocol as evidenced by 
completed the AGREE II Questionnaire. The findings demonstrate that the CHF Practice 
Protocol provides clinicians with an evidence-based guidance to manage homebound 
patients with CHF on a small scale.  
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Section 1: Nature of the Project Introduction 
 Congestive heart failure, or CHF, is a chronic medical condition that affects the 
chambers of the heart (Krucik, 2012). Left-sided CHF causes damage to the left ventricle, 
potentially resulting in fluid buildup in the lungs while right-sided CHF may occur in 
conjunction with left-sided CHF or separately, causing difficulty in sending blood to the 
lungs and resulting in fluid buildup in the lower extremities (Krucik, 2012). Over 5.7 
million individuals in the United States alone are diagnosed with CHF, with 
approximately 700,000 new diagnoses of CHF per year (Mosalpuria et al., 2014). The 
disease is characterized by multiple hospital readmissions, averaging out to at least 1 per 
year for over 50% of those diagnosed and mortality rates at approximately 30% 
(Mosalpuria et al., 2014). The prevalence of the disease, lack of proper patient education, 
and mismanagement of the disease and its associated symptoms are some of the more 
common reasons associated with repeat hospitalizations (Mosalpuria et al., 2014). 
Currently, there is no tool for CHF a patient that focuses on patient education and 
managing CHF. The tool developed in this project was created to allow home healthcare 
providers, including physicians, nurse practitioners and physician assistants, the ability to 
monitor and track disease progression.  The ability to manage the disease will increase 
several fold, potentially reducing the number of repeat hospitalizations and reducing the 
mortality rates associated with the disease itself.  The tool was evaluated by clinicians in 
home care and cardiology on its potential of efficacy in practice. 
Patients with CHF were the primary stakeholders in the completion of this 
project; another stakeholder in the program was the visiting nurse associations (VNAs) 
2 
 
 
who focus on the care of the CHF patient.  VNAs, though certified by Medicare, provide 
different services and allocations of services including nursing, home health aides, and 
therapists.   
VNAs who offer tele-health systems that monitor vital signs including weight, 
blood pressure, and pulse on a daily basis have a staked interest in managing patients 
with heart failure in the home.  The VNAs are the main professionally trained caregivers 
outside of the home and serve as the eyes and ears for the visiting provider group.  A 
third stakeholder group was the visiting provider practice including office staff, 
physicians, and nurse practitioners (NPs). These stakeholders are all board certified by 
their respective bodies and have several years of experience managing chronic disease 
states for homebound patients. 
Relying on information about medications taken, baseline diagnostic criteria, 
baseline measurements, risk factors, and symptom notification parameters, the tool 
developed here is in questionnaire form.  The CHF home care tool will allow the visiting 
provider to evaluate the needs of the patient in his or her home environment looking at 
the living conditions, access to resources, and caregiver support.  In doing this, the tool 
can yield guidance to the patient and his or her provider concerning the management of 
CHF, which may reduce hospitalization rates. The provider is also able to identify the 
patient’s current disease knowledge, willingness to participate in disease management, 
and any inhibiting factors preventing disease management in the home.  The tool 
designed will be used to address the needs of the heart failure patient and to align 
resources and services while they are in the home.  The provider entering the home to 
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provide care will complete the heart failure tool to identify barriers and potential 
complications and give standing orders and visiting recommendations to provide optimal 
care and reduce exacerbations. 
Stakeholder involvement was important for me to complete and analyze 
information for the project.  I coordinated activities and contracts with stakeholders 
required to research the efficacy of the tool.  This included partnerships and the creation 
of standard protocols. Stakeholders included the patients with CHF and participating 
health care providers as well as homecare agencies and their clients. 
 The completion of the project culminated the development of a heart failure tool 
created by a nurse practitioner who works in home care, where clinicians and providers 
will be able to use to identify factors that may lead to exacerbation or hospitalization of 
home bound heart failure patients.  
Problem Statement 
Health care reform has focused on patient outcomes, cost reduction, and recurrent 
hospitalization rates.  Twenty-six percent of patients who are discharged from a hospital 
to home end up back in the hospital within 30 days (Ouslander et al., 2010).  Even with 
discharge planning, patients can become confused and unsure when trying to manage 
changes in medications, follow up care and appointments, and changes in conditions and 
functional capacity after being discharged from the hospital (Dedhia et al., 2009).  
Patients with complex disease states, such as that which is present in those diagnosed 
with CHF, become classified as unmanaged as a result of their inability to process and 
follow the changes being placed in front of them, causing issues in their plan of care and 
4 
 
 
their ability to manage their disease. This results in the patients ultimately going back to 
the hospital for treatment.  Recurrent hospitalizations may be preventable with proper 
interventions including additional medications, patient education, switching to a low 
sodium diet, drug therapies, thyroid therapies, and counseling (CHF Risk Factors and 
Recommended Interventions, n.d.). This tool may be used to decrease the prevalence of 
these hospitalizations. Many of these additional interventions do not require the patient to 
visit the doctor’s office or the hospital for them to start. Currently, there is no tool 
available for NPs and other home healthcare providers who aim at improving the 
management of CHF patients specifically. With such a tool, decreased rates of 
hospitalization can be achieved for CHF patients. 
NPs are able to diagnose, treat, and manage acute and chronic disease states, 
including pain. They function in a variety of settings ranging from hospitals, nursing 
homes, clinics, and home care.  NPs are regulated by the Nurse Practice Act in the state 
in which they practice; therefore, NPs practice guidelines vary slightly from state to state 
(Cooper, 2007).  Home care is a growing industry and is considered an underserved 
population.  Many home care clients have complex disease states such as CHF. The 
presence of these NPs within the home healthcare industry works to provide a viable 
alternative for an individual who would be able to administer the CHF Practice Protocol 
being developed herein.  
Purpose Statement 
 The purpose of the project was to design a CHF tool that may be used by a 
provider who makes home visits with patients who are diagnosed with CHF in order to 
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improve the overall efficiency of home-based healthcare options.  CHF has become 
epidemic in our nation, taxing our health care system (Mosalpuria et al., 2014).  The 
subsequent burden of care is foisted off onto the community as a result of the cost of care 
associated with treatment and the overall negative effects on the quality of life of the 
patient and their families (Boyd et al., 2011).  CHF is weakness of the heart to keep up 
the demands of the body and follows a spectrum of severity (Krucik, 2012).  CHF is 
treatable and manageable with medications, lifestyle modifications, and surgical 
treatments (Jessup et al., 2009).  NPs trained in home care and who have an 
understanding of heart failure are capable of managing heart failure patients in the home 
(Cooper, 2007).  The use of a tool for heart failure patients will assist the NP or other 
providers in their coordination of care while allowing the provider to ensure that the 
patient is on a proper follow up and treatment protocol and the set modalities for the 
patient are following evidenced based practices. As such, the purpose of the project was 
to design the CHF Practice Protocol tool that may be used by a provider who makes 
home visits with patients who are diagnosed with CHF in order to work to improve the 
overall efficiency of home-based healthcare options.   
Project Objectives 
The following objective has been identified for the completion of this project: 
 Develop the CHF Practice Protocol tool designed from evidenced-based 
practice and evaluate its effectiveness.   
 Determine the perceived effectiveness and usefulness of the tool with CHF 
patients. 
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Significance and Relevance to Practice 
Healthy People 2020 set a standard to reduce hospitalizations for people who have 
a principal diagnosis of heart failure.  The initiative set forth in the Healthy People 2020 
objectives hopes to obtain a 10% reduction across the board of three targeted areas 
(Healthy People 2020, 2014).  The target age group is an older population aged 65 to 74 
years old with a primary diagnosis of heart failure (Healthy People 2020, 2014).  The 
target is 8.8 hospitalizations per 1,000 people (Healthy People 2020, 2014).  In 2007, 
there were 9.8 hospitalizations per 1,000 people (Healthy People 2020, 2014).  In the age 
group of 75 to 84, there were 22.4 hospitalizations per 1,000 people, and the Healthy 
People 2020 goal is 20.2 per 1,000 people.  Those older individuals 85 years and older 
have 42.9 hospitalizations per 1,000 people and a goal of 38.6 hospitalizations (Healthy 
People 2020, 2011). It is anticipated that through the utilization of the CHF Practice 
Protocol being developed and evaluated that the obtainment of the objectives set forth by 
the Healthy People 2020 initiative will become more attainable than they are in the 
current state of healthcare. 
In addition to financing for medications, health literacy, and inadequate support 
systems, disease management compliance has an impact in reducing hospitalization rates 
(Minott, 2008).  In spite of this proven ability to reduce readmission rates with simple 
compliance, there are many barriers in which CHF patients may not remain compliant 
with their medications or treatments, especially when it comes to heart failure (Grady et 
al., 2000).  Barriers can make patients believe that they are sick only when they are in the 
hospital and/or facility. Thus, patients believe that they do not need to do their treatments 
7 
 
 
or take medication because they are feeling better, reducing compliancy; further 
compliancy issues are brought about by the perceived inability to follow instructions due 
to a lack of understanding or an unwillingness on the part of the patient or their families 
to comply with all of the rules and regulations set forth upon discharge (Grady et al., 
2000). These compliancy barriers may lead to decreased healthcare outcomes for 
patients. 
Issues of complacency are another concern for CHF compliance. Patients are 
lulled into a sense of familiarity and security, believing that all that they have done in the 
past has worked, and thus there is no need to make changes in the future in order to 
further manage the disease; the issue with this mentality arises from the fact that it fails to 
take into account the progression of the disease, thereby resulting in readmissions (Grady 
et al., 2000; Naylor et al., 2011).  In addition, issues may arise because certain patients do 
not like the way they feel when they are taking certain medications, and as opposed to 
speaking with their doctor regarding the matter, they opt to self-diagnose and simply 
remove the medication from their regimen, causing complications in the treatment of the 
disease (Grady et al., 2000).  Another issue in compliance has to do with the financial 
burden assumed by patients when it comes to paying for medication and provider and 
therapy visit copays (Grady et al., 2000; Ornstein et al., 2011). Individuals may attempt 
to determine for themselves whether or not a given visit or a particular medication is 
essential to treatment, declining to pick up a prescription or participate in a particular 
type of therapy as a means of reducing overall associated costs with the management of 
the disease (Grady et al., 2000; Naylor et al., 2011).  Family and caregiver support are 
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also essential in compliance.  Families and caregivers provide reinforcement of the plan 
of care, and a lack of caregivers may cause an issue with compliance (Afzal et al., 2013). 
 Access to health care is another Healthy People 2020 initiative.  People who have 
heart failure may have access issues due to complex disease states and debility.  Visiting 
provider groups specialize in complex care management in the home (Longworth, 2011).  
These providers focus on disease management and prevention by educating the patient 
and caregiver in regard to disease states.  They are able to see how the patient 
environment affects the disease state of the patient and the support system of the patient.  
The visiting provider can curtail the services needed by the patient by evaluating the 
patient environment (Stall, Nowaczynski, & Sinha, 2013). The express significance of 
this tool is that it provides patients and healthcare providers with improved information to 
manage CHF.  
Evidence-Based Significance of the Project 
In a study by Brock et al. (2013), the researchers looked at hospitalization rates of 
complex disease states wherein patients returned to the hospital with the same diagnosis 
within 30 days of previous discharge.  The study incorporated several disease states, 
including heart failure.  The mean 30 day repeat hospitalization per 1,000 Medicare 
beneficiaries per quarter was 15.21% in 2006-2008 (Brock et al., 2013).   
Repeat hospitalization rates are around 26% within 30 days of hospital discharge 
nationwide on complex disease states, with approximately 67% of those readmissions 
being classified as avoidable if the patients had simply followed their basic plans of care 
(Ouslander et al., 2010).  Implementing close follow up with patients with heart failure 
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through the use of home health care organizations and home care providers who make 
house calls will serve as a means of reducing the readmission rates of patients diagnosed 
with heart failure.  The 30 day repeat hospitalization rate was 26% (19,714) within 30 
days of hospital discharge with a length of stay of 6.5 days (SD 6.14) and with an average 
time range to repeat hospitalization of 13.6 days (SD 8.2; Ouslander et al., 2010). 
Increasing the level of coordination of care present between the hospitals, the patient’s 
regular doctors, and his or her home health providers in conjunction with creating a tool 
to be implemented in assisting to ensure the appropriate levels of care are received should 
work to reduce those overall readmission rates, thus increasing the overall health of 
individuals who fall into this population identifier (CHF patients).  
 The use of a visiting provider who focuses on patients with heart failure and who 
is able to see patients just after discharge to help develop a plan of care, reconcile 
medications, and coordinate services within the community will, logically, help reduce 
recurrent hospitalizations as it will serve to increase overall continuity of care (Minott, 
2008).  Having a visiting practitioner meet with CHF patients in their home within 1 
week of being discharged from the hospital and providing the patient with both close 
follow up on their condition, offering additional education opportunities, and working to 
reconcile the new information received by the patient with their previous actions taken as 
a part of their daily routine for CHF maintenance.  It will be possible to ensure that the 
patients have the information that they need, that continuity is maintained, and that 
patients are less likely to become noncompliant with the information they have received 
as a result of their discharge plan (Naylor et al., 2011; Ornstein et al., 2011).  
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Implications for Social Change in Practice 
 To make appreciable social changes in any society, research and technology must 
continue to progress and adapt to the patient environment. The CHF Practice Protocol 
developed as part of this project is specifically designed to provide nurses a highly useful 
tool for at-home patients. By targeting this specific group of patients, the social changes 
expected will involve this group specifically. Providing a reliable and timely tool for 
patients will likely improve patient outcomes, while the continued development and 
improvement of the CHF Practice Protocol will further enhance the efficacy of the tool. 
Definitions of Terms 
Congestive heart failure: A chronic medical condition that affects the chambers of 
the heart (Krucik, 2012). 
Elevated jugular venous pulsation: Distention of the jugular veins when the patient 
is sitting at a 45 degree angle (Figuera & Peters, 2006). 
Home care: Health care that occurs primarily or exclusively at one’s own home 
performed by a certified Home Health Agency such as a VNA.  It may be paid privately 
or through insurance such as Medicare.  Visiting provider groups are physicians, nurse 
practitioners, and physician assistants who provide primary care in the home.  In addition, 
home care may include care provided by nurses, certified home health aides and nursing 
assistance on a nonmedical basis.  
Repeat hospitalization: A patient being hospitalized for one condition, in this case 
CHF, or set of symptoms after having been hospitalized before for the same condition or 
set of symptoms.  
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Tele-health or tele-care: Health care received through the telecommunication 
systems such as via telephone or audio-visual correspondence.  
Assumptions and Limitations 
It is an assumption of this project that there is real need within the home 
healthcare population, due to the increased number of readmissions indicated for CHF 
patients within the literature, for a home care CHF tool. A limitation of this study is that 
the sample of NPs and other professionals to evaluate the CHF tool is somewhat small 
and not highly representative of similar professionals across the country. While this 
project served to develop and improve an at-home CHF tool, future studies can rely on 
other samples.  
Summary 
With more than 5 million individuals in the United States diagnosed with CHF, 
and approximately 700,000 new diagnoses annually (Mosalpuria et al., 2014), there is a 
need for solutions to accurately and actively manage CHF. The prevalence of CHF, the 
lack of proper patient education, and the mismanagement of the disease are typical 
reasons for the repeat hospitalization of CHF patients (Mosalpuria et al., 2014). 
Currently, there is no tool that has been found in the literature that works on the 
transitional management of discharged CHF patients that focuses on patient education 
and managing CHF. The tool created as part of this project to allow homecare 
professionals the ability to monitor and track disease progression and the ability to 
manage the disease will increase substantially, potentially reducing the number of repeat 
hospitalizations and reducing the mortality rates associated with the disease itself.  
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Section 2: Review of Literature and Theoretical and Conceptual Framework  
A review of the relevant literature revealed that heart failure can be effectively 
managed in homebound patients with the proper interventions. A literature search, 
focusing on the last 5 years was conducted between December 2013 to April 2014 using 
Pubmed®, CINAHL®, and Google Scholar® and using the search terms congestive heart 
failure, CHF, visiting provider group, heart failure management, nurse practitioner, and 
Visiting Nurse Association.  Over 10,000 articles were initially identified.  By combining 
search terms and applying relevancy criteria, the search was narrowed to 106 possible 
studies. 
General Literature Review 
 Diagnosing CHF can be accomplished with considerable accuracy through a 
variety of means and “should be considered in the differential diagnosis of any adult 
patient who presents with dyspnea and/or respiratory failure” (Figuera & Peters, 2006, p. 
403). According to Figuera and Peters (2006), successfully diagnosing CHF often hinges 
on a determination of the patient’s history and a complete physical examination, along 
with an assessment of a patient’s characteristic chest radiograph findings. In addition, a 
measurement of serum brain natriuretic peptide, as well as echocardiography, has 
substantially improved the accuracy of the diagnosis of CHF (Figuera & Peters, 2006). 
While the researchers hold that an investigation of one’s medical history is insufficient by 
itself for a CHF diagnosis, such a history can provide clues as to the specific cause, such 
as uncontrolled hypertension or myocardial infarction (Figuera & Peters, 2006). 
Symptoms of CHF are generally related to the reduction of cardiac output, leaving the 
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patient feeling weak or fatigued, or to an excess of fluid retention, which is shown by 
cardiac wheezing, dyspnea, or orthopnea (Figuera & Peters, 2006). Symptoms can also 
present as hepatic congestion, which includes discomfort in the right upper-quadrant, or 
early satiety, discomfort while bending, and anorexia (Figuera & Peters, 2006). Fluid 
retention can result in the form of peripheral edema and even increasing abdominal girth, 
which is secondary to ascites (Figuera & Peters, 2006). When there is no dyspnea upon 
exertion, heart failure due to left-ventricular dysfunction can be ruled out (Figuera & 
Peters, 2006). Crackles may present too, though studies show that they only present in 
approximately 20% of patients with CHF (Figuera & Peters, 2006). Finally, edema in the 
lower extremity presents in roughly one-quarter of patients who are younger than 70 
years of age (Figuera & Peters, 2006). 
 The presence of elevated jugular venous pulsation is considered the most reliable 
indicator of volume overload and is estimated by the distention of the jugular veins when 
the patient is sitting at a 45 degree angle (Figuera & Peters, 2006). Volume overload 
indicates elevated pulmonary-artery occlusion pressure around 80% of the time (Figuera 
& Peters, 2006). Also, ventricular enlargement is estimated through precordial palpation, 
an apical pulsation that is displaced lateral to the midclavicular line, which is typically 
indicative of left-ventricular enlargement (Figuera & Peters, 2006). For patients 
experiencing dyspnea, chest radiography results may be useful as a first test for 
differentiating patients with primary pulmonary disease from those with heart failure 
(Figuera & Peters, 2006). 
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 McMurray et al. (2012) argued that the diagnosis of CHF can be quite difficult in 
the early stages of the diseases, generally due to the nature of the symptoms presenting 
for CHF patients. Such symptoms tend to be nonspecific, leaving practitioners unable to 
differentiate between diagnoses of CHF and other diseases (McMurray et al., 2012). 
However, in later stages of CHF, symptoms become considerably more specific, allowing 
for more accurate diagnoses (McMurray et al., 2012). Sodium and water retention related 
symptoms are some of the slightly more specific symptoms of the later stages of CHF, 
while orthopnea and paroxysmal nocturnal dyspnea are much more specific, though much 
less common (McMurray et al., 2012). Other specific signs include elevated jugular 
venous pressure and, on occasion, displacement of the apical impulse; these two signs are 
much more difficult to detect in patients and are, thus, less reproducible (McMurray et 
al., 2012). Symptoms vary with other conditions and characteristics in patients, such as 
age, weight, and the presence of chronic lung disease (McMurray et al., 2012). Typical 
symptoms for CHF are breathlessness, orthopnea, paroxysmal nocturnal dyspnea, 
reduced exercise tolerance, fatigue, tiredness, increased recover time after exercise, and 
ankle swelling (McMurray et al., 2012). Less typical symptoms include nocturnal 
coughing, wheezing, weight gain, feelings of being bloated, loss of appetite, confusion, 
depression, palpitations, and syncope (McMurray et al., 2012). Specific signs include 
elevated jugular venous pressure, hepatojugular reflux, third heart sound (gallop rhythm), 
laterally displaced apical impulse, and cardiac murmur (McMurray et al., 2012). Less 
specific signs include peripheral edema, pulmonary crepitation, reduced air entry, 
dullness to percussion at lung bases, tachycardia, irregular pulse, tachypnea, 
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hepatomegaly, ascites, and tissue wasting (McMurray et al., 2012). Upon an accurate 
diagnosis, the most important next step to proper treatment is identifying the cause of the 
CHF (McMurray et al., 2012). 
 Swedberg et al. (2005) and Liu and Eisen (2014) discussed the available diagnosis 
means for CHF. Electrocardiogram results often change upon CHF (Liu & Eisen, 2014; 
Swedberg et al., 2005). Chest x-rays are useful for detecting cardiomegaly and 
pulmonary congestion (Swedberg et al., 2005). Hematology and biochemistry methods, 
such as blood count and measuring levels of S-creatinine and S-glucose, are common in 
diagnosing CHF (Liu & Eisen, 2014; Swedberg et al., 2005). Detecting the plasma 
concentrations of certain natriuretic peptides is also helpful in diagnosing CHF (Liu & 
Eisen, 2014; Swedberg et al., 2005). Echocardiography is a preferred method for 
documenting cardiac dysfunction at rest (Liu & Eisen, 2014; Swedberg et al., 2005). 
Cardiac magnetic resonance imaging is a highly accurate and versatile technique for 
assessing the volumes of the right and left ventricles as well as other important conditions 
(Liu & Eisen, 2014; Swedberg et al., 2005). Assessing pulmonary function and exercise 
tests are also common (Liu & Eisen, 2014; Swedberg et al., 2005). 
 A study by Jerant, Azari, and Nesbitt (2001) revealed that a home tele-care 
intervention service could significantly reduce the number of hospital admissions in 
patients with histories of CHF. The 1-year randomized trial included patients who were 
40 years of age or older and who had been diagnosed with CHF. The patients were 
divided into three groups: home tele-care, telephone care, and usual care. Through the use 
of two-way doctor-to-patient video conferences, the tele-care group had fewer hospital 
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readmissions due to CHF and its related symptoms and also left much less of a financial 
burden on patients.  
Specific Literature Review 
 In working to determine the most effective means of creating the CHF Practice 
Protocol, it became necessary to review previous attempts at additional monitoring and 
compliance techniques that had been applied to the CHF population. One of the more 
common methodologies that had been attempted and continued to come up in searches of 
relevant literature was the attempted implementation of tele-health alternatives. These 
tele-health practices required a patient to call in to a specific number, reporting their vital 
statistics and other pertinent information in order to determine whether or not the patient 
was staying on track, following their plan of care, and keeping their illness under control 
(Chaduhry et al., 2010).   
Chaduhry et al. (2010) completed a small study that was to identify if tele-health 
monitoring improved health failure outcomes.  The study incorporated 1,653 patients 
who had recently been hospitalized for CHF.  The study participants were split into two 
groups, with individuals who had tele-health options setup for care management in one 
group and individuals who participated in traditional care options only in the second.  
The tele-health group called into a toll-free number and answered the questions regarding 
weight, medication compliance, and symptoms.  The data were collected for 180 days 
and identified any reason for hospitalization or death.  The results concluded there was no 
statistical difference between the repeat hospitalization rates between the two groups, 
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indicating that the additional utilization of tele-health options did not benefit the 
continuity of care of the patient, as was hoped. 
 In another study, Takahasi (2012) reviewed the tele-health management options 
implemented in the population of older adults with multiple health issues.  The 
randomized control trial looked at 205 adults aged 60 and over who were identified as 
high risk for hospitalizations.  Over a 1-year period of time the study showed no 
significant difference between patients who had tele-health interventions as compared to 
the control. This study did not solely identify CHF, but rather included it as well as other 
health issues such as debility, diabetes, and chronic obstructive pulmonary disease.  
 The next possibility addressed in order to identify the best means of CHF tool 
creation was the effectiveness of transitional care in the CHF patient. Transitional care 
options work to provide the patient with a transitory period between leaving the hospital 
and returning straight to their homes, a process that may result in confusion with 
discharge planning, understanding on the part of the patient, and an increased frustration, 
making compliance with orders given less likely. In order to identify the validity of this 
particular option, studies were reviewed which focused on the effectiveness of these 
treatment options.  
 Stauffer et al. (2011) completed a prospective study with concurrent controls on a 
heart failure transitional care program led by advanced practice nurses over a 1-year 
period at Baylor Medical Center at Garland.  The advanced practice nurses were able to 
significantly reduce 30-day hospitalization rates by 48% during the post intervention 
period.  The reduction was better when compared to secular reductions made by other 
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facilities in the same medical system (Stauffer et al., 2011).  The goal of the study was 
determine if Medicare dollars could be saved by having transitional care provided by 
advanced practice nurses.   The study yielded positive results with more than $200 saved 
by patients per hospitalization (Stauffer et al., 2011).  
In a study completed by Brock et al. (2013), which focused on 14 communities 
evaluated, a positive correlation between transitional care management with interventions 
made by providers and decreased hospitalizations was shown.  Between 2009 to 2010, 
transitional care interventions were instilled in 14 communities across the United States, 
some with transitional care interventions and some without.  In Camden, New Jersey, the 
closest geographic location to my location, there was only a 1.58% 30 day repeat 
hospitalization rate.  This rate was significantly lower than that of before (1.89), when 
compared to the previous years without interventions.   This study included CHF, but also 
included other chronic disease states such as pneumonia, chronic obstructive pulmonary 
disease, and falls. In spite of the inclusion of additional illnesses and other reasons for 
medical intervention, the correlation between transitory periods and decreased 
readmission was wholly positive. 
 In a review of the literature completed on this topic, Stall et al. (2013) identified 
eight studies completed in the past 15 years in regards to visiting providers and hospital 
admissions.  Studies reviewed were of a mixed design and included observational, 
retrospective review, and one multisite randomized control trial.  All eight studies 
showed a decrease in hospital admissions from 8% to 84% with a mean 34.8% reduction 
in hospital admissions. 
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 The effectiveness of the transitory care in working to reduce hospital readmission 
rates indicated that the most effective means of implementing the CHF Practice Protocol 
will be through the utilization of a form of transitory care, one that allows the patient the 
ability to go more smoothly between the hospital and a return to their everyday lives.  
The next area of investigation required a determination regarding the 
effectiveness of NP interventions in a targeted patient population. This research was 
necessary in order to determine whether the inclusion of an NP intervention could be 
used in the CHF Practice Protocol’s application. Research into this area returned multiple 
studies regarding the effectiveness of the nurse practitioner within the clinical setting and 
within the home setting. 
In a study conducted by Lowery (2012), a NP-led CHF program within the 
Veteran’s Affairs Medical Center was evaluated for effectiveness over the course of a 2-
year period.  Nine hundred sixty-nine patients participated in the scheduled study. These 
individuals were divided into two groups, with one group receiving interventions by NPs 
whose responsibility it was to counsel patients on disease management and directly 
manage the patients’ CHF medications.  The other group received traditional and “usual 
care.”  The results of the study yielded a significant decrease in hospitalizations, 
including days spent in the hospital and mortality over a 1-year period of time as a result 
of the interventions by the NPs within the clinical setting.  
 Naylor et al. (2011) looked into transitional care and the cost effectiveness of the 
implementation of a transitional care program in the Philadelphia region.  The study used 
patients who were admitted to the University of Pennsylvania Health System and were 
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insured through Aetna’s managed Medicare program; a total of 310 patients were used.  
Costs for the study were $217,000 for provider visits made to the home over a 1-year 
period of time and $164,500 for visiting nurse associations over a 1-year period of time.  
Hospitalization expenses in the transitional care program totaled $3,896,100, as 
compared to the control group, whose hospitalization expenses totaled $4,387,500.  The 
study showed a 3-month health care cost savings of $439 per member and over $2170 
over a 1-year period of time.  The NPs would routinely make house calls to assist in 
disease and medication management as well as coordinate care in the patients’ homes.  
Among the patients there was a significant reduction of 25%in recurrent hospitalizations 
from 60 to 45 (p < 0.041) over the period for those who were receiving NP interventions 
(Naylor et al., 2011). 
 The results of these studies indicate that the utilization of NP interventions in the 
treatment of CHF patients is an ideal form of transitory care that may be employed, one 
that will not only work to decrease overall costs associated with the care for CHF patients 
but that will effectively benefit from the creation of a tool designed to assist in CHF 
management. 
 While the literature has made clear that transitory care serves as a definite benefit 
to the CHF patient in terms of decreasing their overall readmission rates, and the 
utilization of NPs as a means of providing that transitory care is highly effective, this 
does not close down all further avenues of research, simply because the first option that 
shows positive benefits have been found. It is necessary to be thorough in the completion 
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of one’s research, and as such, the next avenue of research into transitory care options 
touched on the beneficence of the visiting provider. 
Stewart (2012) looked at hospital-based interventions of heart failure and home-
based interventions in order to determine which of the two different options provided was 
more effective.  The multicenter randomized control trial involved 280 CHF patients with 
a goal in identifying efficacy of disease management.  Outcomes of the study did not 
yield a significant difference between intervention groups; however, it did show a 
positive correlation in health care costs and a decreased number of days in the hospital 
for those patients who were receiving home based interventions (Stewart et al., 2012). 
The data obtained, while not indicating a significant difference between the two groups, 
indicated that a difference was present.  
 Hernandez et al. (2010) published a study in regards to early physician follow up 
and the 30-day readmission rates of CHF patients.  In the observational analysis, the 
researchers looked at 30,136 patients from 225 hospitals.  The study showed a positive 
relationship between physicians seeing patients within 7 days of being discharged from 
the hospital and the CHF outcomes.  There was a significance of seeing a patient within 
the first 14 days of coming home from the hospital, but not as significant as the first 7 
days.  Early intervention and follow up significantly lowers the risk of 30-day 
readmission (Hernandez et al., 2010).  
 Both studies indicated that the inclusion of a visiting provider worked to decrease 
readmission rates for CHF patients, to varying degrees of effectiveness. This indicated a 
higher likelihood for the utilization of some form of visiting provider in the process of 
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CHF Practice Protocol implementation, as the ultimate goal of the tool itself is to be able 
to work to reduce the overall readmission rate of CHF patients to the hospital, improving 
their overall quality of care, and working to ensure that the appropriate practices and 
procedures are being followed by CHF patients in order to ensure increased health and 
wellness.` 
Summary of Literature Review 
 CHF may be managed by NPs effectively in the home.  Tele-health, though a 
useful tool in help of management of CHF, failed to independently improve 
hospitalization rates (Takahasi, et al., 2012). Transitional care optimizes close follow up 
and disease management and has shown to be effective in managing CHF and decreasing 
hospitalizations (Block et al., 2013).   With close provider follow up, including 
transitional care and seeing the patient within seven days of coming home from the 
hospital helps decrease hospitalizations and improve overall disease management 
(Hernandez, et al., 2010). These overall results point to the development of a tool that 
may be employed following the patient being discharged from the hospital or nursing 
facility and being utilized within the home by a visiting provider, which would offer 
additional means of monitoring and assistance in continuity of care for the patient 
between hospital stays and their typical and traditional doctor’s appointments. The 
creation of such a tool should work to reduce the overall readmission rates to hospitals 
based on evidence as indicated within the literature review itself.  
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Theoretical Framework 
CHF treatment and management in homebound patients in the home would 
greatly benefit from the application of Donabedian’s framework.  The main components 
of this model are structure, process and outcomes.  Donabedian’s framework model was 
used to guide the formulation of the research question and interpret findings (Gardner, 
Gardner & O’Connell, 2014; Johns Hopkins Bloomberg School of Public Health, 2014; 
McDonald, et al., 2007).  The specific framework was chosen on the need to identify NP 
autonomy and disease management (Appendix E).  This framework pioneered efforts 
associated with outcomes in research, and emphasized three factors: structure, process 
and outcomes (Gardner, Gardner & O’Connell, 2014; Johns Hopkins Bloomberg School 
of Public Health, 2014; McDonald, et al., 2007).  Structure identifies nursing autonomy 
in decision making of the NP using two structural variables related to the outcome of the 
patient.  In this specific incidence the variables represent weight gain, edema, medication 
compliance and diet.  Process involves the aspect of decision making and interventions 
made by the clinician.  Outcomes refer to the specific patient outcome; this refers to the 
effects and efficacy of the disease management of the homebound patient (Burns, & 
Grove, 2009). 
The model originally created to describe the effects on the medical professional 
on the overall patient outcome.  Donabedian (1966) stated,  
This is justified by the assumption that one is interested...in whether what is now 
known to be “good” medical care has been applied. Judgments are based on 
considerations such as the appropriateness, completeness and redundancy of 
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information obtained through clinical history, physical examination and 
diagnostic tests; justification of diagnosis and therapy; technical competence in 
the performance of diagnostic and therapeutic procedures, including surgery; 
evidence of preventive management in health and illness; coordination and 
continuity of care; acceptability of care to the recipient and so on. (p. 671)  
 In structuring the questions from the perspective of the model, Donabedian’s 
framework was utilized in the initial design of the CHF Practice Protocol (Appendix A). 
In working to ensure that each of the different areas, structure, process, and outcome, 
were addressed in the design of the tool, it became possible to ensure that all areas of 
concern were appropriately addressed and that the tool itself would be beneficial within 
the context it was created for, thus suggesting that structural factors will affect outcomes 
through the impact of the tool utilization. Nurses using the tool will better be able to 
assess the condition of CHF Practice Protocol at home. The model originally created to 
describe the effects on the medical professional on the overall patient outcome. The 
Donabedian framework is particularly suitable for designing the CHF Practice Protocol 
because this framework is both simple and can offer relatively straightforward means to 
assess the tool.  
Summary 
 A review of the relevant literature reveals that heart failure can be effectively 
managed in homebound patients with the proper interventions and that, in fact, CHF may 
be effectively managed by NPs in the home.  The literature review also reveals that tele-
health, though a useful tool in help of management of CHF, failed to independently 
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improve hospitalization rates of CHF patients (Takahasi, et al., 2012). Meanwhile, 
transitional care optimizes close follow up and disease management and has shown to be 
effective in managing CHF and decreasing hospitalizations (Block et al., 2013). Given 
the results of the literature review, the creation of a home care CHF tool is expected 
reduce the overall readmission rates to hospitals. The Donabedian framework is 
particularly suitable for designing the CHF Practice Protocol because this framework is 
both simple and can offer relatively straightforward means to assess the tool. In fact, the 
model was originally created to describe the effects on the medical professional on the 
overall patient outcome. It was used in this project to build and help review the tool.  
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Section 3: Methodology Approach 
 The CHF Practice Protocol was designed for nurses and providers for use on 
home health care patients. The project itself was designed and created based on a need 
perceived within the home healthcare population as a result of the increased number of 
readmissions indicated for CHF patients within the literature, in combination with the 
readmission rate identified for patients as seen through my position as a NP within the 
field of home healthcare services. While it was clear that the utilization of the transitory 
services offered by the home healthcare services assist patients in reducing their 
readmission rates, it became clear that additional intervention was necessary in order to 
further reduce the readmission rates of these individuals and increase their overall quality 
of life. In order to do so, I applied the framework decided on in order to work to create 
the initial design of the CHF intervention tool shown in Appendix A. The initial design of 
the tool will allowed for providers to recognize problems present, increasing the 
likelihood of an issue being caught and addressed prior to the patient’s condition 
becoming so severe that it warrants admission to the hospital. 
Project Design and Methods 
I disseminated the tool to providers of home health care.  I coordinated with the 
office staff to identify the target population within the practice with a diagnosis code of 
428.0, CHF and health care providers who provide direct care to those patients.  The tool 
was reviewed by providers who are directly related to CHF.  It was reviewed by 
physicians, nurse practitioners, and nurses who directly work with CHF.  These providers 
work in home care, cardiology, hospitalists, and visiting provider groups. A minimum of 
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25 clinicians in multiple specialties and professions were used to evaluate their 
perception of the effectiveness of the CHF Practice Protocol.  Clinicians and providers 
reviewed the tool for completeness and ability to integrate into practice.  Each provider 
evaluated their perception of the tool using a standardized rating scale.  Evaluation of the 
effectiveness of the tool occurred 1 month after releasing the tool via Email, mail, and 
fax. The participant consent form was required to be signed by clinician for the purpose 
of this study’s completion is located in Appendix B. 
Tool Design 
 The design of the CHF Practice Protocol was in the form of a basic questionnaire, 
fit on two standard sheets of paper. The first part of the tool’s design (Appendix B) is 
used as a means of establishing baseline data for the provider to have a better 
understanding on the type of heart failure the patient has as well as other information to 
include baseline reporting information including electrocardiograms and 
echocardiograms as well as the patient ejection factor without the need of the provider to 
pull up the patient’s full medical records to obtain all of the aforementioned data. 
 The second part of the CHF features a version of a tele-health tool, a tool used by 
VNAs as well as other providers to manage disease processes such as heart failure and 
hypertension in the home.  Tele-health equipment is usually setup in the home and 
connects to a monitoring station inside the VNA or other facility and is evaluated by a 
nurse or other medical professional.  The equipment in the home measures blood 
pressure, pulse, weight, and oxygen saturation.  The tool also asked the patient questions 
to include information about medication compliance, chest pain or discomfort, shortness 
28 
 
 
of breath, and the use of additional pillows at night (Chaudhry et al., 2010).  The provider 
or VNA could select the appropriate questions to be asked to the patient that are relevant 
for the patient. 
 The third section of the CHF Practice Protocol asked patients about medications 
that are appropriate for treating heart failure.  Based on the latest standards of care 
published by Current (2014), patients who have heart failure should be on angiotension 
converting enzyme medication such as lisinopril, a beta-blocker such as metoprolol, a 
diuretic such as furosemide, and an antiplatelet such as aspirin (Klein, 2014).   
 The baseline lab information is useful for the provider in evaluating other 
healthcare factors that may exacerbate heart failure such as hypothyroidism, anemia, 
cholesterol, and diabetes (Klein, 2014).  The baseline information regarding the patient’s 
habits and ability level are documented by the provider to accurately identify changes 
from the baseline during phone calls and the tele-health system (Chaudhry et al., 2010).   
 The risk factor and prevention section of the tool is used as a means of identifying 
current comorbid concerns with patients who have heart failure and includes aspects like 
a low sodium diet, smoking, the patient’s weight or body mass index, their fluid 
restrictions as well as the prevalence or absence of their flu and pneumonia vaccine.  This 
information is useful for the provider when working with disease management education 
(Klien, 2014). 
 The second page of the tool begins with a triage scale that I designed and is used 
by the provider to establish visit frequencies.  Patients without support systems or 
medications are at higher risk for hospitalizations (Lowery et al., 2012).  Patients who 
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have a better understanding of heart failure, current prescribed medications, and an 
adequate support system have a better chance of managing heart failure in the home 
(Evangelista et al., 2010).  Patients who do not have an adequate support system, are 
missing medications, and are ambivalent to their heart failure and other comorbid 
diseases are more apt to be readmitted to the hospital (Lowery et al., 2012).   This scale is 
useful for both the provider seeing the patient in the home as well as to the office staff 
when determining when to schedule patients and how much potential follow up will be 
needed between the provider, nursing, and office staff. 
 The provider would then identify areas that are needed by the specific patient.  
Treating the patient as an individual is ideal for managing heart failure in the home 
(Boyde et al., 2011).  This section gives the provider an opportunity to identify key areas 
of need for managing their disease in the home.  This section also directs the provider on 
what to focus on for the next patient visit as well as goals for the visit. 
 The last section of the provider tool is the standing orders that the provider 
establishes with VNAs to decrease the amount of time between disease exacerbation and 
intervention.  Diuretics are the cornerstone of heart failure management (Klein, 2014).  
Having standing orders for the VNA will allow the nurses to interpret tele-health data and 
symptomology and use standing orders to provide patient care without direct provider 
involvement.  This allows quicker decision making by nurses as well as improved patient 
contact, which will allow timelier heart failure interventions (Chaudhry et al., 2010).  The 
standing orders may be used in its entirety or in partial depending on the patient needs.   
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The tool and study was approved by the IRB at Walden University and its approval 
number for this study is 06-03-15-0338510. 
Population and Sampling 
The sampling method employed in this study is convenience sampling and 
involved obtaining information about qualifying patients from patients with heart failure. 
Selected providers who work with either heart failure patients or home care were chosen 
to participate in the evaluation process so that a sample size of at least 25 providers to 
evaluate the tool was achieved.  Providers included physicians, nurses, and NPs who are 
licensed and certified in their respected professions within the state of New Jersey.  
Physicians, nurses, and NPs include cardiology, home care, and hospitalist specialists.   
Patients who are considered to be homebound under the Medicare guidelines and 
standards are visited in their homes and are offered the appropriate interventions and 
assistance as needed and as demanded by their conditions and associated diagnoses.  The 
territory served by Mobile Physician Group is the Southern New Jersey Region covering 
the majority of the three counties just outside of Philadelphia in New Jersey.  The 
majority of patients served by the practice are over the age of 65, have Medicare as their 
primary insurance, and have four or more comorbid conditions.  I am a full-time NP 
employed by the practice. 
The target population is focused on homebound patients who are determined by 
Medicare to be unable to leave their home for greater than short durations due to a taxing 
effort.  This population is set in Southern New Jersey, covering three counties: 
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Burlington, Camden, and Gloucester.  The population incorporates multiple races, males 
and females from ages above 16, with median age of 74.8.   
 Access to health care is another problem for this target population.  People who 
have heart failure may have access issues due to complex disease states and debility.  
Visiting provider groups specialize in complex care management in the home.  These 
providers focus on disease management and prevention by educating the patient and care 
giver in regards to disease states.  They are able to see how the patient environment 
affects the disease state of the patient and the support system of the patient.  The visiting 
provider can curtail the services needed by the patient by evaluating the patient 
environment (Stall et al., 2013). 
Instrument/Data Collection 
The CHF Practice Protocol Tool (Appendix B) was given to various providers 
employing a convenience sampling technique.  Providers included physicians, nurses, 
and nurse practitioners in various institutions and fields including home care clinicians, 
providers, hospitalists, and cardiologists.  A minimal sampling size goal was at least 25 
recipients.  A coversheet provided instructions and collected demographic information on 
the provider completing the information as well as return instructions.  The coversheet 
(Appendix E) was combined with the Tool (Appendix B) and the AGREE II 
Questionnaire (Appendix C).   
In order to evaluate the effectiveness of the developed tool, each provider, both 
physicians and NPs, completed the Appraisal of Guidelines for Research and Evaluation 
(AGREE) questionnaire (See Appendix C). The purpose of the tool was to allow nurses 
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to be able to accurately identify the condition of CHF patients. The questionnaire asks 23 
questions and ranks each question on a 1 to 4 scale from strongly disagree to strongly 
agree on the usage of the CHF Practice Protocol (White & Dudley-Brown, 2012).  The 
provider test results were used to determine if the tool is valid and appropriate to be used 
with patients with heart failure in the home.  This small, micro sample will lead me to 
determine if the tool may fit a more broad scale to incorporate more nurse practitioners 
and providers who provide home care provider services. Additionally, the results of this 
study will help to determine what changes need to be made to the tool.  
 Activities related to the evaluation of the heart failure transitional care program 
included the identification of ways to reduce hospitalization.  By doing so, it required 
advanced practice nurses to make interventions over a 30-day period in terms of 
medication management, early interventions, and disease management to avoid 
hospitalizations.  Early interventions included having the advanced practice nurse visit 
within the first 72 hours, and 24-hour phone support was available for patients to call 
with questions or concerns.  The advanced practice nurse worked with patients over a 3-
month period of time (Stauffer et al., 2011). The data analysis used for this project was a 
comparison of means, in which the mean patient outcomes were compared.  
Data Analysis 
 The data gathered for the evaluation of this heart tool effectiveness came 
primarily from the opinions of medical professionals who received the tool for 
evaluation. Simple descriptive statistics including both percentages and frequencies were 
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tallied based from the feedback received from the medical professionals evaluating the 
tool.  
Project Evaluation Plan 
 After the conclusion of the project and evaluation of the outcomes of the project 
have been analyzed, I determined a positive outcome has occurred by feedback provided 
by the providers.  It was determined that additional research is needed on a larger scale to 
better evaluate the use the heart failure tool in homebound patients (Ketner et al., 2012).   
 The primary evaluation of the CHF Practice Protocol was found to be appropriate 
for use by health care providers who serve patients with heart failure.  Secondary 
evaluation results yielded that proper communication and patient care can seamlessly 
take place between the VNAs, the visiting provider group, and the patient if the 
evidenced based practice is applicable for the homebound patient.    
Summary 
The CHF Practice Protocol was designed for nurses and providers for use on 
home health care patients. The tool was designed and created based on a need perceived 
within the home healthcare population as a result of the increased number of 
readmissions indicated for CHF patients within the literature. The design of the CHF 
Practice Protocol was in the form of a basic questionnaire, fit on two standard sheets of 
paper. The first part of the tool’s design was used to establish baseline data for the 
provider to have a better understanding of the type of heart failure the patient has in 
addition to other basic information. The second part of the CHF features a version of a 
tele-health tool, a tool used by VNAs as well as other providers to manage disease 
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processes such as heart failure and hypertension in the home.  The third section of the 
CHF Practice Protocol asked patients about medications that are appropriate for treating 
heart failure.  The last section of the tool is the standing orders that the provider 
establishes with VNAs to decrease the amount of time between disease exacerbation and 
intervention. During the course of the study, I will disseminate the tool to providers of 
home health care. Such providers will evaluate the effectiveness of the CHF Practice 
Protocol.  
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Section 4: Findings, Discussion, and Implications Data Analysis 
The data gathered for the evaluation of CHF Practice Protocol came from the 
opinions of medical professionals who received the tool for evaluation. Simple 
descriptive statistics were used based on the feedback received from the medical 
professionals evaluating the tool using the AGREE II Questionnaire.  The results of the 
survey indicated strong professional support for the use of the tool (Appendix F). There 
were 32 participants in this study. Twenty-three were registered nurses (RNs), three were 
physicians, five were nurse practitioners, and one participant was a Licensed Practical 
Nurse (LPN). Seven participants operated in a home care setting, 10 were employed in a 
medical/surgical or primary care setting, four were employed in cardiology, and six were 
employed in rehab or nursing home settings. 
As depicted below in Figure 1, 28 respondents answered a 7 out of 7 response for 
the question “Rate the Overall Quality of the Guideline.” Meanwhile, the remaining five 
respondents answered a 6 out of 7 response, indicating very strong support for the 
guideline. 
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Figure 1. Rate of the overall quality of the guideline. 
 
Moreover, 31 of the 32 respondents answered that they would recommend the use 
of the guideline with no modifications. Again, the responses to this question provided 
strong professional support for the guideline. 
In fact, none of the responses had even half of the responses being anything other 
than a 6 or 7 out of 7. There were only two total responses that fell below the neutral 
value of 4 out of 7 for Likert Scale questions. Question 1 of the survey asked whether the 
overall objectives of the guideline are specifically described. As depicted in Figure 2, two 
respondents answered 5 out of 7, five answered 6 out of 7, and 25 answered 7 out of 7, 
again providing strong support for the guideline. 
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Figure 2. The overall objectives of the guideline are specifically described (Q1)  
 
For Question 4, as depicted below in Figure 3, six respondents answered 6 out of 
7, while the remaining 26 answered 7 out of 7.  
 
Figure 3. Guideline development group includes all relevant professional groups (Q4). 
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As shown in Figure 4, only one respondent answered with a 5 out of 7, while four 
responded 6 out of 7 and the remaining 27 responded 7 out of 7.  
 
Figure 4. The views and preferences of the target population have been sought (Q5). 
 
For the question of whether systematic methods were used to search for evidence, 
six respondents answered 6 out of 7, while the remaining 26 responded 7 out of 7, as 
shown in Figure 5 below.  
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Figure 5. Systematic methods were used to search for evidence (Q7). 
  
For Question 11 on whether the health benefits, side effects, and risks have been 
considered, five respondents answered 6 out of 7 and the remaining 28 responded 7 out of 
7 illustrated in Figure 6 below.  
 
40 
 
 
Figure 6. The health benefits, side effects, and risks have been considered (Q11). 
 
In Question 12, the respondents were asked whether there is an explicit link 
between the recommendations and the supporting evidence. As shown in Figure 7 below, 
four respondents answered 6 out of 7, while 28 answered 7 out of 7. 
 
Figure 7.  There is an explicit link between the recommendations and supporting 
evidence (Q12). 
 
The remainder of the questions had similar responses. Aggregately, the responses 
to this questionnaire provide strong support for the use of the guideline among medical 
professionals.  
Discussion 
 The primary evaluation of the CHF Practice Protocol was found to be appropriate 
for use by health care providers who serve patients with heart failure.  The majority of 
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clinicians who evaluated the CHF Practice Protocol found it useful and necessary when 
working with patients who have heart failure.  Implementation in a practice may yield 
similar results as reported by Stuaffer et al. (2011) where advanced practice nurses were 
able to reduce hospitalization rates by 48% through a transition of care program.  The 
project also falls in line with Stall et al. (2013) who identified eight studies in the past 15 
years showing a 84% reduction in hospitalizations using visiting providers to the home 
for patients with complex medical problems. Counseling patients and identifying factors 
that may cause disease exacerbation for patients who have CHF yielded a “significant 
decrease” in hospitalizations (Lowerey, 2012).  The project also shows a correlation to a 
study by Naylor et al. (2011) when transitional care is provided in the Philadelphia region 
for managed care patients led by advanced practice nurses in saving health care costs and 
reducing hospitalizations (Naylor et al., 2011).  
 The research has shown that transitional care, visiting provider groups, and VNAs 
help reduce hospitalizations, help control costs, and decrease disease exacerbations 
(Stewart et al., 2012).  The CHF Practice Protocol incorporates many elements stated in 
the research to help improve outcomes for patients with CHF. 
 After the conclusion of the project and evaluation of the data provided by the 
clinicians who evaluated the perceived effectiveness of the CHF Practice Protocol 
determined the CHF Practice Protocol has merit in the homebound patients with CHF.  It 
is recommended that research be completed on a larger scale to better evaluate the use the 
heart failure tool in homebound patients (Ketner et al., 2012).   
Summary 
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Thirty-two medical professionals participated in the evaluation of a heart failure 
tool on their perception of usefulness in practice.  Thirty-one of the 32 stated that the tool 
would be useful in practice working with heart failure patients.  Based on the feedback 
received from the participants, the heart failure tool has been perceived as helpful when 
working with patients who are homebound and have heart failure.  With a limited 
participant pool, it would be beneficial to expand research and development and test on it 
a larger scale to determine if a heart failure protocol tool is warranted to integrate into 
practice. 
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Section 5: Scholarly Product 
The CHF Practice Protocol was distributed through a snowball distribution.  
Invitations to participate were sent to over 50 health care professionals in cardiology, 
home care, and hospitalists and included physicians, physician assistants, nurse 
practitioners, and nurses.  Thirty-two health care professionals provided feedback on the 
CHF Practice Protocol over a 1-month period of time.  Of the 32 respondents, only one 
respondent found the tool to be ineffective in current practice.   
Data collected from this small initial study showed that the CHF Practice Protocol 
has a place in the homebound patient with heart failure.  Further testing and evaluation of 
the tool in a larger study would be beneficial to determine if it  should be integrated into a 
practice.  
Findings from this initial project may be disseminated through a peer-reviewed 
journal. The Journal of American Association of Nurse Practitioners is a peer-reviewed 
nursing journal focused on evidenced-based practice, research, case studies, legislation, 
health care policy, practice improvement, and other issues related to advanced practice 
nursing.  The journal has been published monthly for over 27 years.  It is a subscription 
distribution that focuses on over 205,000 NPs within the United States (American 
Association of Nurse Practitioners, 2015).  The journal has requirements for publication, 
which would allow me to publish the findings as part of my doctoral degree. 
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Strengths 
The CHF Practice Protocol was found to be appropriate for use by health care 
providers who serve patients with heart failure.  Study results displayed positive feedback 
on the CHF Practice Protocol design and a desire to implement them in both a skilled 
nursing facility and in a home care environment.      
Limitations 
 Research was only gathered on a small sample size of 32 after a snowballing 
campaign over a month in small geographic area.  A larger sample size that covers a 
larger geographical area would strengthen the validity of the study.  Secondly, I did not 
account for feedback from healthcare providers who do not operate in home care, nursing 
facilities cardiology specialists, and hospitalists.  Additional research on a larger scale to 
is needed to better evaluate the use the CHF Practice Protocol in homebound patients 
(Ketner et al., 2012).   
Self Analysis 
At the conclusion of the project, I have grown significantly as an NP who works 
with patients with CHF.  I have researched CHF and have developed peer-reviewed tool 
to determine its perceived efficacy in practice.  I had challenges obtaining feedback 
results from peers, as the project involvement was voluntary.  However, this has 
strengthened my commitment to my profession and my role as a NP who provides home 
based care.  The project reinforced the evidenced-based research that NPs are able to 
manage patients with CHF and manage these disease states in their home to reduce 
hospitalizations.   
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Over the doctoral education, I have become a stronger leader in the community as 
well as NP.  I continue to bring evidenced-based practice into the profession, teach NP 
students, precept NP clinical students, and serve as a mentor for fellow NPs who work in 
home care.  I will continue to serve as a mentor, teacher, and provider in the community.  
I will also continue to work for legislative changes for NPs at the state and national level.  
Summary 
The development and evaluation of a heart failure tool for homebound patients 
was a project completed for a Doctorate Degree of Nursing Practice at Walden 
University.  The project has been ongoing for the past 3 years and incorporated classroom 
education on epidemiology, clinical research, and writing as the precursor for the 
development of the project.  The topic was identified as an area of concern as I am a 
clinical NP who works in a home care based practice in New Jersey and I manage a lot of 
heart failure patients.  I identified that many patients who have CHF undergo many 
hospitalizations.  My goal of completing the project was to design a tool that identifies 
the risk factors, disease management, and supportive services that affect homebound heat 
failure patients.  I then distributed the tool to healthcare professionals who work in 
hospitals, home care, nursing facilities, and cardiology practices to determine if a tool of 
this nature has merit.  Feedback received yielded a positive response regarding the tool, 
thus suggesting that a tool may be used to help reduce hospitalization rates for people 
who have CHF. 
The project was completed on a small scale using a snowball-sampling technique.  
Additional studies need to be completed on a larger scale on its perceived efficacy into 
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practice as well as a small study to incorporate into actual practice to determine if the tool 
is able to reduce hospitalizations. 
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Appendix A: Donabedian Framework in Heart Failure 
 
 
• Structure identifies nursing autonomy in decision making of the nurse practitioner 
using two structural variables related to the outcome of the patient 
• Process involves the aspect of decision making and interventions made by the 
clinician 
• Outcomes refer to the specific patient outcome; this refers to the effects and 
efficacy of the disease management of the homebound patient (Burns, & Grove, 
2009). 
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Appendix B: CHF Practice Protocol 
 
Patient Name _________________________________  DOB ________________  Date ________________ 
 
Diastolic _____  Systolic _____ Comorbid Conditions?  __________________________________________ 
 
Date of last Echo? _______________  EF? _________  Date of last EKG? _________________   
 
VNA Ordered _____  Bayada _____  Moorestown VNA _____  Virtua VNA _____ 
Tele-health _____  PT/OT _____  MSW _____ HHA _____  Other _________________________________ 
 
Medications (name, dose and frequency) 
ACE/ARB  ______________________________   Diuretic  ______________________________ 
Beta-Blocker ______________________________   Anti-platelet ______________________________ 
Statin  ______________________________   Digoxin  ______________________________ 
 
Baseline Diagnostics with interpretation 
EKG __________________ CBC __________________ HbA1c __________________ 
CMP __________________  TSH __________________ Lipids __________________ 
 
Baseline Measurements 
Height _____  Weight _____  BMI _______  Blood Pressure __________  Pulse _______  SpO2 _______ 
Edema (characteristics) ______________________________ 
Shortness of Breath (activity) ______________________________ 
Number of pillows used at night ______________________________ 
Ambulatory distance (number of blocks, feet, or miles) ______________________________ 
 
Risk Factors/Prevention 
Healthy Weight?  Yes_____  No _____  Plan __________________________________________________ 
Smoking Cessation?  Yes _____  No _____  Plan _______________________________________________ 
Low Sodium Diet?  Yes _____  No _____  Plan ________________________________________________ 
Water Restriction?  Yes _____  No _____  Plan ________________________________________________ 
Assistive Device/ADL Support?  Yes _____  No _____  Plan _____________________________________ 
Barriers?  Yes _____  No _____  Plan ________________________________________________________ 
Flu Vaccine (annual) _______________  Pneumococcal (Every 5 years) _______________ 
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Physician/Nurse Practitioner Visit Pattern Based on Severity 
 Stable – labs, EKG and echo up to date.  Medications reviewed, reconciled.  No caregiver or compliance concerns.  
Follow up in four weeks.  VNA established. 
 Less Urgent – requires at least one lab, EKG or echo.  One or more medications are missing or unable to reconcile 
all medications.  Questionable caregiver support or potential for compliance concerns.  VNA involvement likely to 
be refused or unable to start promptly.  Follow up in two weeks. 
 Urgent – missing multiple labs, EKG and echo.  Mildly symptomatic of no more than one or two symptoms, but 
symptoms are not emergent.  Able to stabilize with stock medications or minimal interventions.   Missing multiple 
prescribed medications.  Caregiver missing and has patient with unmet needs.  VNA not present in patient care.  
Follow up in a few days or one week. 
 Emergent – patient actively symptomatic where immediate intervention is required.  Patient is not safe in current 
home environment.  Attempt to stabilize and send out and call 911.   
 
Provider Identified Areas of Need: 
_________________________________________________________________________________________ 
 
Goals for Next Visit: 
_________________________________________________________________________________________ 
 
Symptom Management for VNA/Tele-Health* 
Notification Parameters 
Change in Weight (2 pounds/24 hours or 5 pounds/7 days) _______________________ 
SBP ________________  DBP ________________  Pulse ________________  SpO2 __________ 
Standing Nursing Orders: 
_____ For weight changes outside of above parameters: 
_____ Add new PRN diuretic order (specify if ongoing order or for a specific number of days) 
Medication __________________________  Dose ____________ Frequency _____________ 
_____ Increase current daily oral diuretic _________________________  to dose of _____________ 
_____ Initiate new medication _________________  at a dose of __________ frequency __________ 
_____ Home care nurse to draw BMP within 3-5 days of change in diuretic or specified medication. 
_____ If BP or Heart Rate is above/below above specified parameters over _____ consecutive days make the 
following change to patient’s medication regimen: 
Medication __________________________  Dose ____________ Frequency _____________ 
_____ Other orders ____________________________________________________________________ 
* Utilize nursing judgment when possible.  Send severe/uncontrollable cases to emergency room as well as patients 
with extreme dyspnea on exertion, and/or chest pain. 
 
______________________  __________  ______________________ __________ 
Provider Name   Date   Provider Signature  Date 
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Appendix C: AGREE II 
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Appendix D: Evaluation Tool Approval 
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Appendix E: Donabedian Model 
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Appendix F: Data Statistics - Heart Failure Tool Evaluation Using Agree II 
Questionnaire 
 
       Title 
   
Practice Setting 
 MD/DO 3 
  
Home Care 12 
NP/PA 5 
  
Med/Surg/Primary  10 
RN 23 
  
Cardiology 4 
LPN 1 
  
SNF/Rehab 6 
Total 32 
     
       
       
       Question 1 
     1 2 3 4 5 6 7 
    
2 5 25 
       Question 2 
     1 2 3 4 5 6 7 
    
2 6 24 
       Question 3 
     1 2 3 4 5 6 7 
    
1 4 27 
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Question 4 
     1 2 3 4 5 6 7 
     
6 26 
       Question 5 
     1 2 3 4 5 6 7 
    
1 4 27 
       Question 6 
     1 2 3 4 5 6 7 
     
4 28 
       Question 7 
     1 2 3 4 5 6 7 
     
6 26 
       Question 8 
     1 2 3 4 5 6 7 
     
4 28 
       Question 9 
     1 2 3 4 5 6 7 
    
1 5 26 
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Question 10 
     1 2 3 4 5 6 7 
     
4 28 
       Question 11 
     1 2 3 4 5 6 7 
     
5 28 
       Question 12 
     1 2 3 4 5 6 7 
     
4 28 
       Question 13 
     1 2 3 4 5 6 7 
   
1 1 5 25 
       Question 14 
     1 2 3 4 5 6 7 
 
1 
  
2 7 22 
       Question 15 
     1 2 3 4 5 6 7 
    
1 6 25 
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Question 16 
     1 2 3 4 5 6 7 
     
6 26 
       Question 17 
     1 2 3 4 5 6 7 
     
6 26 
       Question 18 
     1 2 3 4 5 6 7 
   
1 1 4 26 
       Question 19 
     1 2 3 4 5 6 7 
     
4 28 
       Question 20 
     1 2 3 4 5 6 7 
     
4 28 
       Question 21 
     1 2 3 4 5 6 7 
     
2 30 
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Question 22 
     1 2 3 4 5 6 7 
     
3 29 
       Question 23 
     1 2 3 4 5 6 7 
 
1 
  
1 2 28 
       1: Quality 
      1 2 3 4 5 6 7 
     
5 28 
       2: Recommend for use 
    
Yes 
Yes with 
Modifications No 
  31 
 
0 
 
1 
   
 
